PSIWM
BSX icon

Paradigm Strategies in Wealth Management’s Boston Scientific BSX Stock Holding History

Paradigm Strategies in Wealth Management’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-251
Closed -$11K – 70
2021
Q2 		$11K Hold
251
– – 0.01% 162
2021
Q1 		$10K Buy
+251
New +$9.5K 0.01% 156

Other funds holding BSX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BG
Bollard Group Boston, Massachusetts $3.39B AUM 1.06% 1-Year Est. Return

Paradigm Strategies in Wealth Management's BSX Position: Q3 2021 in Review

Paradigm Strategies in Wealth Management sold out of Boston Scientific (BSX) in Q3 2021, closing a stake of 251 shares — an estimated $11K sold.

Paradigm Strategies in Wealth Management first reported a position in BSX in Q1 2021 and held it in 2 quarters. The position peaked at $11K in Q2 2021. 877 funds tracked by Wall St. Rank hold BSX as of Q3 2021.

  • Paradigm Strategies in Wealth Management reported no remaining Boston Scientific position as of Q3 2021 after selling out during the quarter.
  • Paradigm Strategies in Wealth Management sold 251 Boston Scientific shares in Q3 2021, an estimated $11K.
  • Paradigm Strategies in Wealth Management first reported a position in Boston Scientific in Q1 2021 and held it in 2 quarters.
  • Paradigm Strategies in Wealth Management's Boston Scientific position peaked at $11K in Q2 2021.
  • 877 funds tracked by Wall St. Rank held Boston Scientific as of Q3 2021.

Based on Paradigm Strategies in Wealth Management's 13F filing for Q3 2021, filed 15 Oct 2021.